medigraphic.com

2014, Number 2

<< Back Next >>

Rev Hematol Mex 2014; 15 (2)

Training in Hematopoietic Stem Cell Aceptado: 6 de mayo 2014 Transplant in Latin America: Current Situation. Latin American Bone Marrow Transplantation Group (LABMT)

Sotomayor C, Seber A, Bonfim C, Bouzas L, Bujan W, Daudt L, Gómez-Almaguer D, González-Ramella Ó, Gregianin L, Hamerschlak N, Hernández M, Jaimovich G, Olaya-Vargas A, Ruiz-Argüelles G, Simões B, Teixeira G, Zecchin V, Palma J

Language: Spanish
References: 15
Page: 37-42
PDF size: 477.84 Kb.


ABSTRACT

Background: The Latin American Bone Marrow Transplantation Group (LABMT) goal is to promote excellence in hematopoietic stem cell transplantation (HSCT) in Latin America.
Objective: To know data about HSCT training programs in Latin America.
Material and method: An online survey was conducted in January and February 2014. The survey was sent to 35 persons who had attended the initial meetings of the LABMT.
Results: We received answer from 16 programs (4 pediatric centers, 1 adults center and 11 combined centers), from 6 different countries. One-year fellowship programs were offered in 12 centers. The 16 training programs develop their activities in centers where matched sibling donor HSCT are performed, fifteen of them in centres where alternative HSCT are also performed.
Conclusions: This data seem to be the first one concerning HSCT training centres in Latin America. These programs represent an opportunity to train Latin American physicians within Latin America, in their native language, exposed to similar social, economic and cultural realities, at lower costs and closer to their homeland.


REFERENCES

  1. Gajewski JL, LeMaistre CF, Silver SM, et al. Impending challenges in the hematopoietic stem cell transplantation physician workforce. Biol Blood Marrow Transplant 2009;15(12):1493-1501.

  2. Gratwohl A, Baldomero H, Gratwohl M, et al. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica 2013;98:1282-1290.

  3. Latin American Bone Marrow Transplantation Group (LABMT) Bylaws, http://www.wbmt.org/fileadmin/pdf/10_LABMT/ LABMT_Bylaws_20140110.pdf. Consultado el 26 de marzo de 2014.

  4. Ciurea SO, Saliba RM, Hamerschlak N, et al. Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant. Leuk Lymphoma 2012;53:901-906.

  5. Ruiz-Delgado GJ, Mancías-Guerra C, Macías-Gallardo J, González-Llano O, et al. Long term results of placental blood allografting using reduced-intensity conditioning: Multicenter experience in a developing country. Hematology 2011;16:155-159.

  6. Palma J, Salas L, Carrión F, et al. Haploidentical stem cell transplantation for children with high-risk leukemia. Pediatr Blood Cancer 2012;59:895-901.

  7. Rodríguez-Romo L, González-Llano O, Mancias-Guerra C, et al. Pediatric hematopoietic SCT in Mexico: recent activity and main problems. Bone Marrow Transplant 2011;46:607-609.

  8. Silla L, Fischer GB, Paz A, et al. Patient socioeconomic status as a prognostic factor for allo-SCT. Bone Marrow Transplant 2009;43:571-577.

  9. Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas’ disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transpl Infect Dis 1999;1:135-137.

  10. Palma J, Sasso DF, Dufort G, et al. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America. Bone Marrow Transplant 2012;47:522-527.

  11. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous hematopoietic stem cell transplantation for type 1 diabetes. Ann N Y Acad Sci 2008;1150:220-229.

  12. Hamerschlak N, Rodrigues M, Moraes DA, et al. Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG. Bone Marrow Transplant 2010;45:239-248.

  13. Thakar MS, Bonfim C, Sandmaier BM, et al. Cyclophosphamide- based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. Pediatr Hematol Oncol 2012;29:568-578.

  14. Goss PE, Lee BL, Badovinac-Crnjevic T, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol 2013;14:391-436.

  15. Eckrich M, Pasquini M. Hematopoietic cell transplantation in Latin America. Hematology 2012;17:189-191.




2020     |     www.medigraphic.com